DiaMedica Therapeutics Inc. (NASDAQ: DMAC)
$5.3600
-0.0150 ( +0.19% ) 18.4K
DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is principally engaged in the business activity of developing treatments for unmet clinical needs or where no therapies are available with a primary focus on chronic kidney disease and acute ischemicstroke. Its pipeline product DM199 is a recombinant form of human tissue kallikrein-1.
Market Data
Open
$5.3600
Previous close
$5.3750
Volume
18.4K
Market cap
$228.13M
Day range
$5.2300 - $5.5050
52 week range
$2.1400 - $6.4100
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Jun 03, 2024 |
4 | Insider transactions | 1 | Jun 03, 2024 |
4 | Insider transactions | 1 | Jun 03, 2024 |
4 | Insider transactions | 1 | Jun 03, 2024 |
4 | Insider transactions | 1 | Jun 03, 2024 |
4 | Insider transactions | 1 | Jun 03, 2024 |
4 | Insider transactions | 1 | Jun 03, 2024 |
4 | Insider transactions | 1 | Jun 03, 2024 |
8-k | 8K-related | 15 | May 23, 2024 |
10-q | Quarterly Reports | 62 | May 08, 2024 |